Being eNRGy Conscious: Understanding NRG1 Fusions
Continuing Education is no longer available for the webinar.
Description:
View this webinar to discuss NRG1 fusions in cancer including the physiology (and pathophysiology) of NRG1 signaling, lab considerations and clinical implications. Attend this webinar and get answers to the most pressing questions such as:
- Why are NRG1 fusions so difficult to detect (and how should we test for them)?
- What do these fusions mean for the patient?
- And what are the new treatments directed to these molecular targets?
Learning Objectives:
- Describe the pathophysiology of NRG1 fusions in cancer
- Identify the preferred method of testing for NRG1 fusions
- Discuss the clinical significance of NRG1 fusions in lung cancer
 |
 |
|---|---|
|
Speaker:
Stephen Liu, MD Georgetown University |
Moderator:
Kurtis Davies, PhD |
Duration: 1 Hour
Level of Instruction: Intermediate
Date Recorded: April 12, 2023
Date Recorded: April 12, 2023
- Click the "Register Now" Button
- Log in using your AMP credentials. If you do not have an AMP account, Create a FREE account.
- Complete the "Demographic questionnaire for Emerging and Evolving Biomarkers Series" before the webinar date. You will only need to do this once for the entire series.
Continuing Education Credit Information
Continuing Education is no longer available for the webinar.Note: Members of AMP can access this webinar at no cost. Join the AMP Family!
All sales are final. No refunds will be issued.
No digital files may be reproduced or transmitted in any form, by any means, electronic or mechanical. By purchasing a product, you agree to not share any of the course materials, including videos, downloadable slide presentations, outlines, manuscripts, etc. without explicit and written permission from AMP.
